行情

PACB

PACB

太平洋生物科学
NASDAQ

实时行情|Nasdaq Last Sale

28.02
-1.49
-5.05%
盘后: 28.09 +0.07 +0.25% 17:31 06/15 EDT
开盘
29.31
昨收
29.51
最高
29.45
最低
27.81
成交量
136.72万
成交额
--
52周最高
53.69
52周最低
3.350
市值
55.58亿
市盈率(TTM)
-68.6596
分时
5日
1月
3月
1年
5年
Cathie Wood的方舟在特斯拉进一步加重负荷并削减了苹果的利益
Cathie Wood-led Ark Investment Management on Tuesday snapped up $27.2 million worth of shares in Tesla Inc (NASDAQ: TSLA) after a two-week gap during which shares of the electric vehicle company have retreated about 15%.
Benzinga · 05/19 04:32
生物技术日报：Spero获得NIAID资助，葛兰素史克发布COVID-19数据，BioNTech获得新的CFO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17)
Benzinga · 05/18 11:44
凯茜·伍德（Cathie Wood）几乎完全削减了苹果的股权—并购买了更多的Coinbase
Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ: AAPL) and continued to snap up shares of Coinbase Global Inc (NASDAQ: COIN).
Benzinga · 05/18 05:20
凯茜·伍德（Cathie Wood）买入2600万美元的迪士尼股份并在Netflix出售1300万美元：你需要知道的
Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and entertainment company as analysts pointed to benefits from the reopening of theme parks...
Benzinga · 05/17 03:33
“ SPACs攻击”回顾：回顾8项SPAC交易以及最新的SPAC标题和收益
Last week featured eight announced SPAC deals. The week also had earnings from several well-known former SPACs. Here is a look back at the week that was SPACs for deals and headline news, all covered on Benzinga’s “SPACs Attack.”
Benzinga · 05/16 21:35
在今天的交易中，十只医疗保健股表现出异常的期权活动
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices...
Benzinga · 05/14 16:36
Cathie Wood在盈利日抛售了3360万美元的阿里巴巴股票
Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first operating loss as a listed company, as a record regulatory fine it was
Benzinga · 05/14 05:04
临床肿瘤学下一代测序（NGS）市场回顾和分析报告
May 12, 2021 (MARKITWIRED via COMTEX) -- Next-generation sequencing refers to the identification of the nucleotides of DNA base pairs for the diagnosis of...
Markitwired · 05/12 07:59
更多
财务预测
实际值（美元）
预测值（美元）
利润表更多
净利润（美元）
同比（%）
资产负债表更多
总资产（美元）
总负债（美元）
资产负债率（%）
现金流表更多
经营现金流（美元）
同比（%）
了解PACB最新的财务预测，通过PACB每股收益，每股净资产，每股现金流等数据分析太平洋生物科学近期的经营情况，然后做出明智的投资选择。
分析师评级

5位分析师的综合评级

买入

免责声明：分析师观点仅供投资者决策参考，不构成任何买卖投资建议。

目标价格预测
分析师预测PACB价格均价为51.50，最高价位62.00，最低价为45.00。
EPS
机构持股
总机构数: 343
机构持股: 1.76亿
持股比例: 88.70%
总股本: 1.98亿
类型机构数股数
增持
77
1,444.59万
建仓
78
698.48万
减持
77
2,334.69万
平仓
27
549.43万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
先进医疗设备和技术
-0.22%
医疗设备和用品
-0.19%
高管信息
Chairman/Independent Director
John Milligan
President/Chief Executive Officer/Director
Christian Henry
Chief Financial Officer
Susan Kim
Lead Director/Independent Director
Bill Ericson
Chief Operating Officer
Mark Van Oene
Senior Vice President
Catherine Ball
Senior Vice President
Denis Zaccarin
Chief Accounting Officer
Michele Farmer
Other
Peter Fromen
Director
Kathy Ordonez
Independent Director
David Botstein
Independent Director
William Ericson
Independent Director
Randall Livingston
Independent Director
Marshall Mohr
Independent Director
Lucy Shapiro
暂无数据
  • 全部
  • 财务报告
  • 内部人交易
更多
PACB 简况
Pacific Biosciences of California, Inc.设计、开发并制造测序系统，帮助科学家解决遗传学复杂问题。该公司的单分子实时（SMRT）技术可实现生物进程的单分子实时检测。基于其SMRT技术，该公司推出了PacBio RS II系统。它提供SMRT细胞、Phospholinked核苷酸以及PacBio RS II和Sequel仪器。基于该公司的SMRT测序技术，其产品通过从头测序基因组识别、注释和解密基因组结构，通过全长转录物分析改进参考基因组的注释、表征选择性拼接亚型并找到基因，通过靶向测序表征遗传变异，以及通过脱氧核糖核酸（DNA）修正标识帮助表征表观遗传调控和DNA损伤。

微牛提供Pacific Biosciences of California Inc(NASDAQ-PACB)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的PACB股票新闻，以帮助您做出投资决策。

模拟交易：模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易PACB股票基本功能。